- Home
- EDRY vs BNGO Comparison
EDRY vs BNGO Comparison
Compare EDRY & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDRY
- BNGO
- Stock Information
- Founded
- EDRY 2018
- BNGO 2003
- Country
- EDRY Greece
- BNGO United States
- Employees
- EDRY N/A
- BNGO N/A
- Industry
- EDRY Marine Transportation
- BNGO Biotechnology: Laboratory Analytical Instruments
- Sector
- EDRY Consumer Discretionary
- BNGO Industrials
- Exchange
- EDRY Nasdaq
- BNGO Nasdaq
- Market Cap
- EDRY 25.2M
- BNGO 24.3M
- IPO Year
- EDRY N/A
- BNGO 2018
- Fundamental
- Price
- EDRY $10.24
- BNGO $3.40
- Analyst Decision
- EDRY
- BNGO Buy
- Analyst Count
- EDRY 0
- BNGO 5
- Target Price
- EDRY N/A
- BNGO $7.33
- AVG Volume (30 Days)
- EDRY 8.2K
- BNGO 73.9K
- Earning Date
- EDRY 06-05-2025
- BNGO 08-06-2025
- Dividend Yield
- EDRY N/A
- BNGO N/A
- EPS Growth
- EDRY N/A
- BNGO N/A
- EPS
- EDRY N/A
- BNGO N/A
- Revenue
- EDRY $55,867,583.00
- BNGO $28,464,000.00
- Revenue This Year
- EDRY N/A
- BNGO N/A
- Revenue Next Year
- EDRY $28.27
- BNGO $15.54
- P/E Ratio
- EDRY N/A
- BNGO N/A
- Revenue Growth
- EDRY 10.25
- BNGO N/A
- 52 Week Low
- EDRY $7.60
- BNGO $2.68
- 52 Week High
- EDRY $24.80
- BNGO $44.94
- Technical
- Relative Strength Index (RSI)
- EDRY 52.46
- BNGO 43.73
- Support Level
- EDRY $8.95
- BNGO $3.18
- Resistance Level
- EDRY $9.34
- BNGO $3.47
- Average True Range (ATR)
- EDRY 0.53
- BNGO 0.17
- MACD
- EDRY 0.06
- BNGO -0.01
- Stochastic Oscillator
- EDRY 28.60
- BNGO 36.67
About EDRY EuroDry Ltd.
EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulk such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers. It operates under one operating and one reportable segment, that of operating dry bulk vessels.
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.